Publications - Robert C . Miller, M.D.

Back to Research Profile

1. Macdonald OK, Kruse JJ, Miller JM, Garces YI, Brown PD, Miller RC, Foote RL. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Int J Radiat Oncol Biol Phys 2009 Nov 1; 75(3):950-8.
   View PubMed
2. Miller RC, Iott MJ, Corsini MM. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium. Int J Radiat Oncol Biol Phys 2009 Oct 1; 75(2):364-8.
   View PubMed
3. Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, Bhatia S, Nagorney DM. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys 2009 Sep 1; 75(1):150-5. Epub 2009 Mar 16.
   View PubMed
4. Jacobs NL, Que FG, Miller RC, Vege SS, Farnell MB, Jatoi A. Cumulative Morbidity and Late Mortality in Long-Term Survivors of Exocrine Pancreas Cancer. J Gastrointest Cancer 2009 Aug 29. [Epub ahead of print]
   View PubMed
5. Albain KS, Swann RS, Rusch VW, Turrisi AT, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara DR, Fry WA, Darling G, Johnson DH, Green MR, Miller RC, Ley J, Sause WT, Cox JD. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009 Aug 1; 374(9687):379-86.
   View PubMed
6. Albain K, Swann R, Rusch V, Turrisi a, Shepherd F, Smith C, Prof Chen Y, Livingston R, Feins R, Gandara R, Fry W, Darling G, Johnson D, Green M, Miller R, Ley J, Sause W, Cox J. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. The Lancet 2009 Jul 27. [Epub ahead of print]
   View PubMed
7. Pica A, Miller R, Villa S, Kadish SP, Anacak Y, Abusaris H, Ozyigit G, Baumert BG, Zaucha R, Haller G, Weber DC. The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys 2009 Jul 15; 74(4):1114-20.
   View PubMed
8. Schomas DA, Quevedo JF, Donahue JM, Nichols Iii FC, Romero Y, Miller RC. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic. Dis Esophagus 2009 Jun 09. [Epub ahead of print]
   View PubMed
9. Daniels TB, Pollock BE, Miller RC, Lucchinetti CF, Leavitt JA, Brown PD. Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report. J Neurooncol 2009 Jun; 93(2):263-7.
   View PubMed
10. Daniels TB, Pollock BE, Miller RC, Lucchinetti CF, Leavitt JA, Brown PD. Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report. J Neurooncol 2009 Jun; 93(2):263-7. Epub 2008 Dec 20.
    View PubMed
11. Nguyen TD, Azria D, Brochon D, Poortmans P, Miller RC, Scandolaro L, Majewski W, Krengli M, Abacioglu U, Moretti L, Villa S, Akyol F, Jovenin N. Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: A retrospective rare cancer network study. Crit Rev Oncol Hematol 2009 May 4. [Epub ahead of print]
    View PubMed
12. Schomas DA, Miller RC, Donohue JH, Gill S, Thurmes PJ, Haddock MG, Quevedo JF, Gunderson LL. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience. Ann Surg 2009 Apr; 249(4):588-95.
    View PubMed
13. Bardia A, Greeno E, Miller R, Alberts S, Dozois E, Haddock M, Limburg P. Is a solitary inguinal lymph node metastasis from adenocarcinoma of the rectum really a metastasis? Colorectal Dis 2009 Feb 25. [Epub ahead of print]
    View PubMed
14. Donahue JM, Nichols FC, Li Z, Schomas DA, Allen MS, Cassivi SD, Jatoi A, Miller RC, Wigle DA, Shen KR, Deschamps C. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg 2009 Feb; 87(2):392-8; discussion 398-9.
    View PubMed
15. Botros M, Quevedo F, Miller R. Angiosarcoma of the Liver After Multimodality Therapy for Gallbladder Carcinoma. Radiology and Oncology 2009; 43(2):126-131. [Epub ahead of print]
    View PubMed
16. Botros M, Quevedo JF, Miller RC. Angiosarcoma of the liver after multimodality therapy for gallbladder carcinoma. Radiol Oncol 2009; 42(2):126-131. [Epub ahead of print]
    View PubMed
17. Nguyen TD, Azria D, Brochonc D, Poortmans P, Miller RC. Cancers de prostate: Quelle place pour la radiotherapie a visee curative chez les patients age? Travail coopératif du Rare Cancer Network (RCN). Cancer Radiothérapie 2009; in press. [Epub ahead of print]
    View PubMed
18. Stein ME, Bernstein Z, Abacioglu U, Sengoz M, Miller RC, Meirovitz A, Zouhair A, Freixa SV, Poortmans PH, Ash R, Kuten A. Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer network. Am J Med Sci 2008 Dec; 336(6):478-88.
    View PubMed
19. Martenson JA, Halyard MY, Sloan JA, Proulx GM, Miller RC, Deming RL, Dick SJ, Johnson HA, Tai TH, Zhu AW, Keit J, Stien KJ, Atherton PJ. Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA. J Clin Oncol 2008 Nov 10; 26(32):5248-53. Epub 2008 Sep 02.
    View PubMed
20. Iott MJ, Corsini MM, Miller RC. Evidence-based guidelines for adjuvant therapy for resected adenocarcinoma of the pancreas. Clin J Oncol Nurs 2008 Aug; 12(4):599-605.
    View PubMed
21. Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia S, Iott MJ, Gunderson LL. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol 2008 Jul 20; 26(21):3511-6.
    View PubMed
22. Pinn ME, Gold DG, Petersen IA, Osborn TG, Brown PD, Miller RC. Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys 2008 Jun 1; 71(2):498-506. Epub 2007 Dec 31.
    View PubMed
23. Mell LK, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, Jani AB, Kindler HL, Mundt AJ, Roeske JC, Chmura SJ. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008 Apr 1; 70(5):1431-7. Epub 2007 Nov 08.
    View PubMed
24. Gold DG, Miller RC, Pinn ME, Osborn TG, Petersen IA, Brown PD. Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: association with connective tissue disorder severity. Radiother Oncol 2008 Apr; 87(1):127-31. Epub 2007 Dec 26.
    View PubMed
25. Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villa S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A, Rare Cancer Network. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Gynecol Oncol 2008 Feb; 108(2):298-305. Epub 2007 Dec 21.
    View PubMed
26. Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villa S, Poortmans PMP, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A. Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN). Gynecol Oncol 2008 Feb; 108(2):298-305.
    View PubMed
27. Gines A, Cassivi SD, Martenson JA Jr, Schleck C, Deschamps C, Sinicrope FA, Alberts SR, Murray JA, Zinsmeister AR, Vazquez-Sequeiros E, Nichols FC 3rd, Miller RC, Quevedo JF, Allen MS, Alexander JA, Zais T, Haddock MG, Romero Y. Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer. Dis Esophagus 2008; 21(3):241-50.
    View PubMed
28. Stein M, Kuten A, Bedrnstein Z, Abacioglu U, Sengoz M, Miller R, Meirovitz A, Zouhair A, Villà S, Poortmans P, Ash R. “Small cell (neuroendocrine) carcinoma of the prostate: Etiology, diagnosis, prognosis and therapeutic implications. A retrospective study of 30 patients from the Rare Cancer Network” The American Journal of the Medical Sciences 2008; 336(6):478-488.
    View PubMed
29. Miller R, Iott M, Corsini M. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS Symposium. Int J Radiat Oncol Biol Phys in press 2008.
    View PubMed
30. Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 2007 Oct 10; 25(29):4581-6.
    View PubMed
31. Foote RL, Brown PD, Garces YI, Okuno SH, Miller RC, Strome SE. Informed consent in advanced laryngeal cancer. Head Neck 2007 Mar; 29(3):230-5.
    View PubMed
32. Gold DG, Miller RC, Petersen IA, Osborn TG. Radiotherapy for malignancy in patients with scleroderma: The Mayo Clinic experience. Int J Radiat Oncol Biol Phys 2007 Feb 1; 67(2):559-67.
    View PubMed
33. Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys 2007 Feb 1; 67(2):410-6.
    View PubMed
34. McKean H, Miller RC, Jatoi A. Non-traumatic vertebral fractures in patients with locally advanced esophageal cancer: a previously unreported, unrecognized problem. Dis Esophagus 2007; 20(2):102-6.
    View PubMed
35. Pinn ME, Austin LM, Schomas DA, Miller RC. Case report from Mayo Clinic: Locally advanced Bartholin gland carcinoma. Radiology and Oncology 41(2); 72-79 2007; 41(2):72-79.
    View PubMed
36. Miller RC, Lachance DH, Lucchinetti CF, Keegan BM, Gavrilova RH, Brown PD, Weinshenker BG, Rodriguez M. Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys 2006 Nov 15; 66(4):1178-86. Epub 2006 Sep 11.
    View PubMed
37. Bhatia S, Miller RC, Haddock MG, Donohue JH, Krishnan S. Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys 2006 Oct 1; 66(2):514-9. Epub 2006 Jul 25.
    View PubMed
38. Ozyar E, Selek U, Laskar S, Uzel O, Anacak Y, Ben-Arush M, Polychronopoulou S, Akman F, Wolden SL, Sarihan S, Miller RC, Ozsahin M, Abacioglu U, Martin M, Caloglu M, Scandolaro L, Szutowicz E, Atahan IL. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study. Radiother Oncol 2006 Oct; 81(1):39-46. Epub 2006 Sep 11.
    View PubMed
39. Weber DC, Miller RC, Villa S, Hanssens P, Baumert BG, Castadot P, Varlet P, Abacioglu U, Igdem S, Szutowicz E, Nishioka H, Hofer S, Rutz HP, Ozsahin M, Taghian A, Mirimanoff RO. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2006 Sep 1; 66(1):179-86. Epub 2006 Jul 11.
    View PubMed
40. Miller RC, Villa S, Kamer S, Pasquier D, Poortmans P, Micke O, Call TG. Palliative treatment of Erdheim-Chester disease with radiotherapy: a Rare Cancer Network study. Radiother Oncol 2006 Sep; 80(3):323-6. Epub 2006 Sep 07.
    View PubMed
41. Omlin A, Amichetti M, Azria D, Cole BF, Fourneret P, Poortmans P, Naehrig D, Miller RC, Krengli M, Gutierrez Miguelez C, Morgan D, Goldberg H, Scandolaro L, Gastelblum P, Ozsahin M, Dohr D, Christie D, Oppitz U, Abacioglu U, Gruber G. Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 2006 Aug; 7(8):652-6.
    View PubMed
42. Monnard V, Sun A, Epelbaum R, Poortmans P, Miller RC, Verschueren T, Scandolaro L, Villa S, Majno SB, Ostermann S, Ozsahin M, Mirimanoff RO. Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study. Int J Radiat Oncol Biol Phys 2006 Jul 1; 65(3):817-23. Epub 2006 Mar 15.
    View PubMed
43. Pilepich MV, Paulus R, St Clair W, Brasacchio RA, Rostock R, Miller RC. Phase III study of pentosanpolysulfate (PPS) in treatment of gastrointestinal tract sequelae of radiotherapy. Am J Clin Oncol 2006 Apr; 29(2):132-7.
    View PubMed
44. Miller RC, Haddock MG, Petersen IA, Gunderson LL, Furth AF. Intraoperative electron-beam radiotherapy and ureteral obstruction. Int J Radiat Oncol Biol Phys 2006 Mar 1; 64(3):792-8. Epub 2005 Oct 21.
    View PubMed
45. Miller RC, Haddock MG, Gunderson LL, Donohue JH, Trastek VF, Alberts SR, Deschamps C. Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas. Dis Esophagus 2006; 19(6):487-95.
    View PubMed
46. Miller RC, Haddock MG, Gunderson LL, Donohue JH, Trastek VF, Alberts SR, Deschamps C. Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas. Dis Esophagus 2006; 19(6):487-95.
    View PubMed
47. McKian KP, Miller RC, Cassivi SD, Jatoi A. Curing patients with locally advanced esophageal cancer: an update on multimodality therapy. Dis Esophagus 2006; 19(6):448-53.
    View PubMed